BCHE and dementia: A previous study found that the thickness of the substantia innominata, a potential proxy of cholinergic basal forebrain integrity (18), was associated with rates of cognitive change in 82 AD dementia patients during 9 months of treatment with a cholinesterase inhibitor, with smaller rates of cognitive decline in people with a lower thickness of the substantia innominata (19).